Independent effect of body mass index variation on amyloid-β positivity
- PMID: 35936766
- PMCID: PMC9354132
- DOI: 10.3389/fnagi.2022.924550
Independent effect of body mass index variation on amyloid-β positivity
Abstract
Objectives: The relationship of body mass index (BMI) changes and variability with amyloid-β (Aβ) deposition remained unclear, although there were growing evidence that BMI is associated with the risk of developing cognitive impairment or AD dementia. To determine whether BMI changes and BMI variability affected Aβ positivity, we investigated the association of BMI changes and BMI variability with Aβ positivity, as assessed by PET in a non-demented population.
Methods: We retrospectively recruited 1,035 non-demented participants ≥50 years of age who underwent Aβ PET and had at least three BMI measurements in the memory clinic at Samsung Medical Center. To investigate the association between BMI change and variability with Aβ deposition, we performed multivariable logistic regression. Further distinctive underlying features of BMI subgroups were examined by employing a cluster analysis model.
Results: Decreased (odds ratio [OR] = 1.68, 95% confidence interval [CI] 1.16-2.42) or increased BMI (OR = 1.60, 95% CI 1.11-2.32) was associated with a greater risk of Aβ positivity after controlling for age, sex, APOE e4 genotype, years of education, hypertension, diabetes, baseline BMI, and BMI variability. A greater BMI variability (OR = 1.73, 95% CI 1.07-2.80) was associated with a greater risk of Aβ positivity after controlling for age, sex, APOE e4 genotype, years of education, hypertension, diabetes, baseline BMI, and BMI change. We also identified BMI subgroups showing a greater risk of Aβ positivity.
Conclusion: Our findings suggest that participants with BMI change, especially those with greater BMI variability, are more vulnerable to Aβ deposition regardless of baseline BMI. Furthermore, our results may contribute to the design of strategies to prevent Aβ deposition with respect to weight control.
Keywords: Alzheimer’s disease; BMI change; BMI variability; amyloid-β (Aβ); body mass index (BMI).
Copyright © 2022 Kang, Kim, Chang, Cheon, Choe, Jang, Kim, Koh, Na, Kim and Seo.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Gender-specific relationship between thigh muscle and fat mass and brain amyloid-β positivity.Alzheimers Res Ther. 2022 Oct 4;14(1):145. doi: 10.1186/s13195-022-01086-5. Alzheimers Res Ther. 2022. PMID: 36195949 Free PMC article.
-
Association between APOE ε2 and Aβ burden in patients with Alzheimer- and vascular-type cognitive impairment.Neurology. 2020 Oct 27;95(17):e2354-e2365. doi: 10.1212/WNL.0000000000010811. Epub 2020 Sep 14. Neurology. 2020. PMID: 32928967 Free PMC article.
-
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.Lancet Neurol. 2013 Apr;12(4):357-67. doi: 10.1016/S1474-4422(13)70044-9. Epub 2013 Mar 8. Lancet Neurol. 2013. PMID: 23477989
-
Amyloid-β Positivity Predicts Cognitive Decline but Cognition Predicts Progression to Amyloid-β Positivity.Biol Psychiatry. 2020 May 1;87(9):819-828. doi: 10.1016/j.biopsych.2019.12.021. Epub 2020 Jan 7. Biol Psychiatry. 2020. PMID: 32067693 Free PMC article.
-
Detecting Amyloid Positivity in Elderly With Increased Risk of Cognitive Decline.Front Aging Neurosci. 2020 Jul 30;12:228. doi: 10.3389/fnagi.2020.00228. eCollection 2020. Front Aging Neurosci. 2020. PMID: 32848707 Free PMC article.
Cited by
-
Gender-specific relationship between thigh muscle and fat mass and brain amyloid-β positivity.Alzheimers Res Ther. 2022 Oct 4;14(1):145. doi: 10.1186/s13195-022-01086-5. Alzheimers Res Ther. 2022. PMID: 36195949 Free PMC article.
-
Different associations between body mass index and Alzheimer's markers depending on metabolic health.Alzheimers Res Ther. 2024 Aug 29;16(1):194. doi: 10.1186/s13195-024-01563-z. Alzheimers Res Ther. 2024. PMID: 39210402 Free PMC article.
-
Fasting glucose variability and risk of dementia in Parkinson's disease: a 9-year longitudinal follow-up study of a nationwide cohort.Front Aging Neurosci. 2024 Jan 3;15:1292524. doi: 10.3389/fnagi.2023.1292524. eCollection 2023. Front Aging Neurosci. 2024. PMID: 38235038 Free PMC article.
-
Plasma Alzheimer's disease biomarker variability: Amyloid-independent and amyloid-dependent factors.Alzheimers Dement. 2025 Jan;21(1):e14368. doi: 10.1002/alz.14368. Epub 2024 Nov 13. Alzheimers Dement. 2025. PMID: 39535473 Free PMC article.
-
Sarcopenia is a predictor for Alzheimer's continuum and related clinical outcomes.Sci Rep. 2024 Sep 10;14(1):21074. doi: 10.1038/s41598-024-62918-y. Sci Rep. 2024. PMID: 39256402 Free PMC article.
References
-
- Bilmes J. (1998). A Gentle Tutorial of the EM Algorithm and its Application to Parameter Estimation for Gaussian Mixture and Hidden Markov Models.
-
- Buchman A. S., Capuano A. W., VanderHorst V., Wilson R. S., Oveisgharan S., Schneider J. A., et al. (2021). Brain β-amyloid links the association of change in BMI with cognitive decline in community-dwelling older adults. J. Gerontol. A Biol. Sci. Med. Sci. Online ahead of print. 10.1093/gerona/glab320 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous